paclitaxel polymeric micelles for injection

DRUG4 trials

Sponsors

Jiangsu Cancer Institute & Hospital, Shanghai Yizhong Pharmaceutical Co., Ltd., Liu Huang

Conditions

Breast CancerCholangiocarcinomaEsophageal CarcinomaLung CancerMetastatic Breast Cancer (MBC)Non-squamous NSCLCPancreatic AdenocarcinomaPancreatic Cancer Metastatic

Phase 2

Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC

Not yet recruitingNCT05782426

Jiangsu Cancer Institute & HospitalNon-squamous NSCLC

Start: 2023-03-15End: 2026-01-31Target: 28Updated: 2023-03-23

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

RecruitingNCT06199895

Liu HuangBreast Cancer, Cholangiocarcinoma, Esophageal Carcinoma +3

Start: 2023-11-28End: 2025-11-30Target: 25Updated: 2025-06-03

Phase 3

Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer

RecruitingNCT06143553

Shanghai Yizhong Pharmaceutical Co., Ltd.Metastatic Breast Cancer (MBC)

Start: 2023-09-25End: 2025-12-31Target: 168Updated: 2024-11-29

Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer

RecruitingNCT06752811

Shanghai Yizhong Pharmaceutical Co., Ltd.Pancreatic Cancer Metastatic

Start: 2025-02-05End: 2027-12-31Target: 416Updated: 2026-02-10